This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
California: A law passed in September 2021 prohibits using “metrics,” like a quota on number of prescriptionsfilled, to evaluate a pharmacist’s productivity. We also signed onto APhA’s and the National Alliance of State Pharmacy Associations’ Pharmacist’s Fundamental Responsibilities and Rights document.
The NHC requests more clarity on how CMS will exclude QALY-based metrics and highlight when they have been removed from consideration in MFP justification documentation. Retrieved from [link] content/uploads/2022/05/NHC-FTC-PBM-Comments-Final-Plain-Letterhead.pdf iv Kyle, M., 2022 AMA prior authorization (PA) physician survey.
We recommend that CMS offer more specific sub-questions, similar to other questions in the document, aimed at prioritizing the identification of health disparities that may affect access to and outcomes from the selected drug. 2022 AMA prior authorization (PA) physician survey. and Keating, N. Journal of Clinical Oncology, 42(8).
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content